Guidance

COVID-19: evaluation of commercially available diagnostic products

Information on how Public Health England (PHE) is evaluating the various commercially available COVID-19 diagnostics products.

Documents

Details

This document summarises the work flow currently being undertaken at PHE to evaluate commercially available COVID-19 diagnostics products and covers the stages involved in this process.

Published 20 March 2020
Last updated 27 March 2020 + show all updates
  1. Updated email address.

  2. First published.